Cohort1: mRNA-1083.1
|
Administration route |
intramuscular injection |
Dosage |
Participants will receive single intramuscular (IM) injection of mRNA-1083.1 at Dose Level B on Day 1 |
Age |
Adult, Older_Adult |
|
Cohort2: mRNA-1083.2
|
Administration route |
intramuscular injection |
Dosage |
Participants will receive single IM injection of mRNA-1083.2 at Dose Level A on Day 1 |
Age |
Adult, Older_Adult |
|
Cohort3: mRNA-1083.3
|
Administration route |
intramuscular injection |
Dosage |
Participants will receive single IM injection of mRNA-1083.3 on Day 1 |
Age |
Adult, Older_Adult |
|
Cohort4: Investigational Influenza Vaccine 1
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort5: Investigational COVID-19 Vaccine 1
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort6: Investigational Influenza Vaccine 2
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort7: Influenza Vaccine 2
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort8: mRNA-1083 Composition 1
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort9: mRNA-1083 Composition 2
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort10: Investigational COVID-19 Vaccine 2
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort11: COVID-19 Vaccine 1
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort12: COVID-19 Vaccine 2
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|
Cohort13: Influenza Vaccine 1
|
Administration route |
intramuscular injection |
Age |
Adult, Older_Adult |
|